Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts
Related Experiment Video
Updated: Nov 30, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Hasan Rehman1, Ankur Kalra2, Ajar Kochar3
1Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Insights
Several Indian registries and quality improvement programs focus on cardiovascular disease (CVD) secondary prevention. Initiatives like TN-STEMI and ACS-QUIK aim to improve patient care and outcomes, highlighting the need for data-driven policy.
Area of Science:
- Cardiovascular disease research
- Public health initiatives in India
- Quality improvement in healthcare
Background:
- Cardiovascular disease (CVD) poses a significant health burden in India.
- Existing registries and quality improvement programs aim to address secondary prevention of CVD.
- Various initiatives have been implemented to assess and enhance CVD care across India.
Purpose of the Study:
- To review existing registries and quality improvement initiatives for secondary CVD prevention in India.
- To evaluate the scope and impact of programs like CREATE, IHRS-AF, THF, TN-STEMI, ACS-QUIK, and PIQIP.
- To identify the need for collaborative efforts and data utilization in CVD policy-making.
Main Methods:
- Analysis of data from established Indian registries (CREATE, IHRS-AF, THF).
- Examination of quality improvement programs focusing on acute coronary syndromes and CVD.
- Review of initiatives aimed at improving revascularization access and outpatient care quality.
Main Results:
- Registries like CREATE, IHRS-AF, and THF primarily focus on data collection.
- The TN-STEMI program specifically targets improving revascularization access post-STEMI.
- ACS-QUIK assessed a quality improvement kit for ACS, and PIQIP provides data on outpatient CVD care.
Conclusions:
- Multiple initiatives exist to improve secondary CVD prevention in India, with varying focuses.
- There is a need for enhanced collaboration among health professionals to identify knowledge and policy gaps.
- Effective utilization of existing and new data by policymakers is crucial for driving impactful CVD prevention strategies.
Abstract:
Several registries and quality improvement initiatives have focused on assessing and improving secondary prevention of CVD in India. While the Treatment and Outcomes of Acute Coronary Syndromes in India (CREATE), Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF), and Trivandrum Heart Failure (THF) registries are limited to collecting data, the Tamil Nadu-ST-Segment Elevation Myocardial Infarction (TN-STEMI) program was aimed at examining and improving access to revascularization after an ST-elevation myocardial infarction (STEMI). The Acute Coronary Syndromes: Quality Improvement in Kerala (ACS-QUIK) study recruited hospitals from the Kerala ACS registry to assess a quality improvement kit for patients with ACS while the Practice Innovation and Clinical Excellence India Quality Improvement Program (PIQIP) provides valuable data on outpatient CVD quality of care. Collaborative efforts between health professionals are needed to assess further gaps in knowledge and policy makers to utilize new and existing data to drive policy-making.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

